Neogen Net Worth
Neogen Net Worth Breakdown | NEOG |
Neogen Net Worth Analysis
Neogen's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Neogen's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Neogen's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Neogen's net worth analysis. One common approach is to calculate Neogen's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Neogen's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Neogen's net worth. This approach calculates the present value of Neogen's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Neogen's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Neogen's net worth. This involves comparing Neogen's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Neogen's net worth relative to its peers.
Enterprise Value |
|
To determine if Neogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Neogen's net worth research are outlined below:
| Neogen had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 924.22 M. Net Loss for the year was (9.42 M) with profit before overhead, payroll, taxes, and interest of 442 M. | |
| Neogen has a poor financial position based on the latest SEC disclosures | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Merit Medical Faces CMS Setback on Wrapsody Pass-Through MMSI Stock News |
Neogen Quarterly Good Will |
|
Neogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Neogen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Neogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 25th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 25th of July 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 31st of May 2023 Last Financial Announcement | View |
Neogen Target Price Consensus
Neogen target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Neogen's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Neogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Neogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Neogen, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationNeogen Target Price Projection
Neogen's current and average target prices are 4.86 and 9.00, respectively. The current price of Neogen is the price at which Neogen is currently trading. On the other hand, Neogen's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Neogen Target Price
Know Neogen's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Neogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neogen backward and forwards among themselves. Neogen's institutional investor refers to the entity that pools money to purchase Neogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bamco Inc | 2025-03-31 | 7.5 M | Champlain Investment Partners, Llc | 2025-03-31 | 6.8 M | Clarkston Capital Partners, Llc | 2025-03-31 | 6.3 M | Geode Capital Management, Llc | 2025-03-31 | 5.1 M | Bank Of America Corp | 2025-03-31 | 4.9 M | Ubs Group Ag | 2025-03-31 | 4.8 M | Shapiro Capital Management Co Inc | 2025-03-31 | 4.6 M | American Capital Management Inc | 2025-03-31 | 4.6 M | King Luther Capital Management Corp | 2025-03-31 | 4.5 M | Blackrock Inc | 2025-03-31 | 31.6 M | Vanguard Group Inc | 2025-03-31 | 23.6 M |
Follow Neogen's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.05 B.Market Cap |
|
Project Neogen's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.01 | 0.01 |
When accessing Neogen's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Neogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Neogen's profitability and make more informed investment decisions.
Evaluate Neogen's management efficiency
The Neogen's current Return On Tangible Assets is estimated to increase to -0.0089. The current Return On Capital Employed is estimated to decrease to 0.01. At this time, Neogen's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The Neogen's current Other Current Assets is estimated to increase to about 67.7 M, while Return On Tangible Assets are forecasted to increase to (0.01). Neogen's management efficiency ratios could be used to measure how well Neogen manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 13.07 | 13.73 | |
| Tangible Book Value Per Share | (2.09) | (1.99) | |
| Enterprise Value Over EBITDA | 17.66 | 16.26 | |
| Price Book Value Ratio | 0.81 | 0.77 | |
| Enterprise Value Multiple | 17.66 | 16.26 | |
| Price Fair Value | 0.81 | 0.77 | |
| Enterprise Value | 3.2 B | 3.4 B |
The management team at Neogen has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Enterprise Value Revenue 2.0354 | Revenue | Quarterly Revenue Growth (0.03) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Neogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Neogen time-series forecasting models is one of many Neogen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Neogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Neogen Earnings Estimation Breakdown
The calculation of Neogen's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Neogen is estimated to be -0.0333 with the future projection ranging from a low of 0.08 to a high of 0.1. Please be aware that this consensus of annual earnings estimates for Neogen is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.08 Lowest | Expected EPS | 0.10 Highest |
Neogen Earnings Projection Consensus
Suppose the current estimates of Neogen's value are higher than the current market price of the Neogen stock. In this case, investors may conclude that Neogen is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Neogen's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of August 2025 | Current EPS (TTM) | |
| 3 | 42.83% | 0.0 | -0.0333 | -2.23 |
Neogen Earnings History
Earnings estimate consensus by Neogen analysts from Wall Street is used by the market to judge Neogen's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Neogen's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Neogen Quarterly Gross Profit |
|
Neogen Earnings per Share Projection vs Actual
Actual Earning per Share of Neogen refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Neogen predict the company's earnings will be in the future. The higher the earnings per share of Neogen, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Neogen Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Neogen, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Neogen should always be considered in relation to other companies to make a more educated investment decision.Neogen Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Neogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-04-07 | 2025-02-28 | 0.115 | 0.1 | -0.015 | 13 | ||
2025-01-07 | 2024-11-30 | 0.09 | 0.11 | 0.02 | 22 | ||
2024-10-08 | 2024-08-31 | 0.08 | 0.07 | -0.01 | 12 | ||
2024-07-30 | 2024-05-31 | 0.12 | 0.1 | -0.02 | 16 | ||
2024-04-09 | 2024-02-29 | 0.14 | 0.12 | -0.02 | 14 | ||
2024-01-09 | 2023-11-30 | 0.14 | 0.11 | -0.03 | 21 | ||
2023-10-10 | 2023-08-31 | 0.13 | 0.11 | -0.02 | 15 | ||
2023-07-27 | 2023-05-31 | -0.04 | 0.14 | 0.18 | 450 | ||
2023-03-30 | 2023-02-28 | -0.01 | 0.04 | 0.05 | 500 | ||
2023-01-05 | 2022-11-30 | 0.03 | -0.19 | -0.22 | 733 | ||
2022-09-27 | 2022-08-31 | 0.14 | 0.05 | -0.09 | 64 | ||
2022-07-26 | 2022-05-31 | 0.12 | 0.14 | 0.02 | 16 | ||
2022-03-24 | 2022-02-28 | 0.15 | 0.05 | -0.1 | 66 | ||
2021-12-21 | 2021-11-30 | 0.17 | 0.1 | -0.07 | 41 | ||
2021-09-21 | 2021-08-31 | 0.16 | 0.16 | 0.0 | 0 | ||
2021-07-20 | 2021-05-31 | 0.17 | 0.15 | -0.02 | 11 | ||
2021-03-23 | 2021-02-28 | 0.13 | 0.13 | 0.0 | 0 | ||
2020-12-22 | 2020-11-30 | 0.16 | 0.15 | -0.01 | 6 | ||
2020-09-22 | 2020-08-31 | 0.14 | 0.15 | 0.01 | 7 | ||
2020-07-21 | 2020-05-31 | 0.15 | 0.16 | 0.01 | 6 | ||
2020-03-24 | 2020-02-29 | 0.14 | 0.12 | -0.02 | 14 | ||
2019-12-23 | 2019-11-30 | 0.16 | 0.16 | 0.0 | 0 | ||
2019-09-24 | 2019-08-31 | 0.15 | 0.14 | -0.01 | 6 | ||
2019-07-23 | 2019-05-31 | 0.15 | 0.15 | 0.0 | 0 | ||
2019-03-26 | 2019-02-28 | 0.14 | 0.13 | -0.01 | 7 | ||
2018-12-20 | 2018-11-30 | 0.15 | 0.16 | 0.01 | 6 | ||
2018-09-25 | 2018-08-31 | 0.14 | 0.14 | 0.0 | 0 | ||
2018-07-17 | 2018-05-31 | 0.15 | 0.17 | 0.02 | 13 | ||
2018-03-22 | 2018-02-28 | 0.12 | 0.11 | -0.01 | 8 | ||
2018-01-03 | 2017-11-30 | 0.13 | 0.13 | 0.0 | 0 | ||
2017-09-19 | 2017-08-31 | 0.12 | 0.12 | 0.0 | 0 | ||
2017-07-18 | 2017-05-31 | 0.12 | 0.12 | 0.0 | 0 | ||
2017-03-21 | 2017-02-28 | 0.1 | 0.1 | 0.0 | 0 | ||
2016-12-21 | 2016-11-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2016-09-27 | 2016-08-31 | 0.1 | 0.1 | 0.0 | 0 | ||
2016-07-19 | 2016-05-31 | 0.1 | 0.1 | 0.0 | 0 | ||
2016-03-23 | 2016-02-29 | 0.09 | 0.08 | -0.01 | 11 | ||
2015-12-21 | 2015-11-30 | 0.1 | 0.09 | -0.01 | 10 | ||
2015-09-21 | 2015-08-31 | 0.1 | 0.09 | -0.01 | 10 | ||
2015-07-21 | 2015-05-31 | 0.09 | 0.09 | 0.0 | 0 | ||
2015-03-26 | 2015-02-28 | 0.09 | 0.08 | -0.01 | 11 | ||
2014-12-18 | 2014-11-30 | 0.08 | 0.08 | 0.0 | 0 | ||
2014-09-22 | 2014-08-31 | 0.09 | 0.09 | 0.0 | 0 | ||
2014-07-22 | 2014-05-31 | 0.08 | 0.08 | 0.0 | 0 | ||
2014-03-25 | 2014-02-28 | 0.07 | 0.07 | 0.0 | 0 | ||
2013-12-19 | 2013-11-30 | 0.08 | 0.06 | -0.02 | 25 | ||
2013-09-24 | 2013-08-31 | 0.08 | 0.08 | 0.0 | 0 | ||
2013-07-23 | 2013-05-31 | 0.08 | 0.07 | -0.01 | 12 | ||
2013-03-26 | 2013-02-28 | 0.07 | 0.07 | 0.0 | 0 | ||
2012-12-20 | 2012-11-30 | 0.07 | 0.07 | 0.0 | 0 | ||
2012-09-25 | 2012-08-31 | 0.07 | 0.07 | 0.0 | 0 | ||
2012-07-24 | 2012-05-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2012-03-27 | 2012-02-29 | 0.05 | 0.06 | 0.01 | 20 | ||
2011-12-22 | 2011-11-30 | 0.07 | 0.06 | -0.01 | 14 | ||
2011-09-27 | 2011-08-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2011-07-26 | 2011-05-31 | 0.06 | 0.06 | 0.0 | 0 | ||
2011-03-22 | 2011-02-28 | 0.05 | 0.05 | 0.0 | 0 | ||
2011-01-04 | 2010-11-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2010-09-23 | 2010-08-31 | 0.06 | 0.06 | 0.0 | 0 | ||
2010-07-20 | 2010-05-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2010-03-29 | 2010-02-28 | 0.04 | 0.04 | 0.0 | 0 | ||
2009-12-18 | 2009-11-30 | 0.05 | 0.05 | 0.0 | 0 | ||
2009-09-24 | 2009-08-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2009-07-21 | 2009-05-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2009-03-19 | 2009-02-28 | 0.03 | 0.03 | 0.0 | 0 | ||
2009-01-06 | 2008-11-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2008-09-24 | 2008-08-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2008-07-22 | 2008-05-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2008-03-25 | 2008-02-29 | 0.03 | 0.03 | 0.0 | 0 | ||
2008-01-03 | 2007-11-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2007-09-27 | 2007-08-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2007-07-24 | 2007-05-31 | 0.03 | 0.03 | 0.0 | 0 | ||
2007-03-27 | 2007-02-28 | 0.02 | 0.02 | 0.0 | 0 | ||
2007-01-04 | 2006-11-30 | 0.03 | 0.03 | 0.0 | 0 | ||
2006-09-26 | 2006-08-31 | 0.03 | 0.03 | 0.0 | 0 | ||
2006-07-25 | 2006-05-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2006-03-23 | 2006-02-28 | 0.02 | 0.02 | 0.0 | 0 | ||
2006-01-05 | 2005-11-30 | 0.03 | 0.03 | 0.0 | 0 | ||
2005-09-29 | 2005-08-31 | 0.02 | 0.03 | 0.01 | 50 | ||
2005-07-26 | 2005-05-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2005-03-24 | 2005-02-28 | 0.02 | 0.02 | 0.0 | 0 | ||
2005-01-06 | 2004-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2004-09-29 | 2004-08-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2004-07-21 | 2004-05-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2004-03-25 | 2004-02-29 | 0.02 | 0.02 | 0.0 | 0 | ||
2004-01-07 | 2003-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2003-09-24 | 2003-08-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2003-07-22 | 2003-05-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2003-03-20 | 2003-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
2003-01-07 | 2002-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2002-09-25 | 2002-08-31 | 0.01 | 0.02 | 0.01 | 100 | ||
2002-07-24 | 2002-05-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2002-03-26 | 2002-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
2001-12-19 | 2001-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2001-09-24 | 2001-08-31 | 0.01 | 0.01 | 0.0 | 0 | ||
2001-07-24 | 2001-05-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2001-03-27 | 2001-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
2001-01-09 | 2000-11-30 | 0.01 | 0.01 | 0.0 | 0 | ||
2000-09-28 | 2000-08-31 | 0.01 | 0.01 | 0.0 | 0 | ||
2000-07-19 | 2000-05-31 | 0.01 | 0.01 | 0.0 | 0 | ||
2000-03-24 | 2000-02-29 | 0.01 | 0.01 | 0.0 | 0 | ||
1999-03-23 | 1999-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
1998-12-16 | 1998-11-30 | 0.01 | 0.01 | 0.0 | 0 | ||
1998-03-25 | 1998-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
1998-01-06 | 1997-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
1997-09-23 | 1997-08-31 | 0.02 | 0.02 | 0.0 | 0 | ||
1997-07-22 | 1997-05-31 | 0.01 | 0.01 | 0.0 | 0 | ||
1997-03-26 | 1997-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
1996-12-18 | 1996-11-30 | 0.01 | 0.01 | 0.0 | 0 | ||
1996-09-16 | 1996-08-31 | 0.01 | 0.01 | 0.0 | 0 | ||
null | null | null | null | null | 0 | ||
1996-03-27 | 1996-02-29 | 0.01 | 0.01 | 0.0 | 0 | ||
1995-12-29 | 1995-11-30 | 0.01 | 0.01 | 0.0 | 0 | ||
1995-10-03 | 1995-08-31 | 0 | 0.01 | 0.01 | 0 | ||
null | null | null | null | null | 0 | ||
1994-12-29 | 1994-11-30 | 0.01 | 0.01 | 0.0 | 0 |
Neogen Corporate Management
| John Moylan | Corporate VP | Profile | |
| Bill Waelke | Head Relations | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Julie Mann | VP Officer | Profile | |
| Kevin Burke | Chief Officer | Profile | |
| Amy Rocklin | Chief Secretary | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share (2.23) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.